Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Hologic, Inc. et al v. Minerva Surgical, Inc.
Case Number:
1:15-cv-01031
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
August 28, 2020
Hologic Gets NovaSure Patent Judgment Bumped Up To $7M
A Delaware federal court on Friday approved a $2 million increase to a patent infringement judgment against Minerva Surgical Inc., saying Hologic Inc. is entitled to roughly $7 million for damages related to infringement of its endometrial ablation treatment NovaSure.
-
May 02, 2019
Minerva's Retrial Bid Nixed In NovaSure Patent Fight
Minerva Surgical Inc.'s attempt to revisit a $5 million patent infringement judgment from a Delaware jury failed Thursday when the judge overseeing the case said the jury's decision was supported by evidence presented during a 10-day trial last year.
-
July 30, 2018
Jury Awards Hologic $5M For NovaSure Patent Infringement
A Delaware federal jury on Friday said Minerva Surgical Inc. should pay Hologic Inc. $4.8 million for infringing a patent covering the endometrial ablation treatment NovaSure, but lessened the blow by finding the infringement wasn't willful.
-
December 15, 2017
PTAB Invalidates Hologic Patent, Rejects Claim Fixes
The Patent Trial and Appeal Board on Friday found a Hologic Inc. medical device patent was invalid and rejected a series of proposed substitute claims, following a recent Federal Circuit ruling many believed gave patent owners a better chance at amending patents in America Invents Act reviews.